HCSG, US4219061086

Healthcare Services Group stock trades at USD 21.05 ahead of Q3 results

Published on 09/28/2026 at 22:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 diluted EPS reached USD 0.32 versus USD 0.22 consensus on July 22, 2026. Analysts set a USD 26.50 average target, while Q3 revenue guidance is USD 475 million to USD 485 million.

HCSG, US4219061086, Illustration mit AI erstellt.

Healthcare Services Group stock (ISIN US4219061086) closed at USD 21.05 on Nasdaq on September 25, 2026, as the company heads toward its scheduled Q3 report on October 21, 2026. The latest operating update showed diluted EPS of USD 0.32 for Q2 2026, above the USD 0.22 consensus estimate.

Q2 earnings beat expectations

According to MarketBeat on September 19, 2026, Healthcare Services Group reported Q2 EPS of USD 0.32 against USD 0.22 consensus. The comparison marks a USD 0.10 beat, while the prior-year quarter had produced a loss of USD 0.44 per share.

Q2 revenue reached USD 470.81 million, compared with analyst estimates of USD 471.22 million, according to MarketBeat. The result puts earnings execution ahead of expectations even as revenue remained below the estimate.

Management guides for Q3 growth

In the Q2 2026 earnings call dated July 22, 2026, Yahoo Finance reported that management expects Q3 revenue of USD 475 million to USD 485 million and reaffirmed a mid-single-digit growth outlook for 2026. Q2 revenue was USD 470.8 million, while Environmental Services generated USD 213.2 million and Dietary Services generated USD 257.6 million.

The call also highlighted a difference in segment margins: Environmental Services posted a 13.3 percent margin, compared with 7.5 percent for Dietary Services. Management said the company had repurchased USD 20.9 million of common stock in Q2, bringing the 2026 year-to-date total to USD 44.9 million.

Analyst target stays above market price

MarketBeat reported on September 19, 2026, that nine analysts held a Moderate Buy consensus and an average 12-month price target of USD 26.50. The same report said UBS raised its target from USD 27.00 to USD 30.00 on July 8, 2026, while Oppenheimer initiated coverage with a USD 28.00 target on August 19, 2026.

Healthcare Services Group's September 25, 2026 Nasdaq close of USD 21.05 was below the 52-week high of USD 25.75 and above the 52-week low of USD 15.13. Market capitalization stood at USD 1.5 billion in the September 19, 2026 market snapshot.

October 21 report sets next checkpoint

Healthcare Services Group is scheduled to report Q3 2026 results before the market opens on October 21, 2026, according to MarketBeat. The published consensus calls for Q3 EPS of USD 0.24 and revenue of USD 480.80 million, giving investors a defined checkpoint for the company's growth and margin execution.